These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 39000217)
1. Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer's Disease and Other Neuropsychiatric Disorders: Promising Targets in a Therapeutic Strategy. Żulińska S; Strosznajder AK; Strosznajder JB Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000217 [TBL] [Abstract][Full Text] [Related]
2. The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer's Disease and Other Neurodegenerative Disorders. Wójtowicz S; Strosznajder AK; Jeżyna M; Strosznajder JB Neurochem Res; 2020 May; 45(5):972-988. PubMed ID: 32170673 [TBL] [Abstract][Full Text] [Related]
3. The Strategy of Targeting Peroxisome Proliferator-Activated Receptor (PPAR) in the Treatment of Neuropsychiatric Disorders. Matrisciano F; Pinna G Adv Exp Med Biol; 2023; 1411():513-535. PubMed ID: 36949324 [TBL] [Abstract][Full Text] [Related]
4. Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets. Dey AD; Mannan A; Dhiman S; Singh TG Psychopharmacology (Berl); 2024 Aug; 241(8):1491-1516. PubMed ID: 38801530 [TBL] [Abstract][Full Text] [Related]
5. Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration. Durai P; Beeraka NM; Ramachandrappa HVP; Krishnan P; Gudur P; Raghavendra NM; Ravanappa PKB Curr Neuropharmacol; 2022; 20(5):893-915. PubMed ID: 34751120 [TBL] [Abstract][Full Text] [Related]
6. Alzheimer's Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α. Sáez-Orellana F; Octave JN; Pierrot N Cells; 2020 May; 9(5):. PubMed ID: 32422896 [TBL] [Abstract][Full Text] [Related]
7. Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease. Sose PM; Kale PP; Doshi GM CNS Neurol Disord Drug Targets; 2024; 23(8):956-970. PubMed ID: 37670711 [TBL] [Abstract][Full Text] [Related]
8. Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders? Tufano M; Pinna G Molecules; 2020 Feb; 25(5):. PubMed ID: 32120979 [TBL] [Abstract][Full Text] [Related]
9. Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer's Disease? Martens N; Zhan N; Voortman G; Leijten FPJ; van Rheenen C; van Leerdam S; Geng X; Huybrechts M; Liu H; Jonker JW; Kuipers F; Lütjohann D; Vanmierlo T; Mulder MT Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447330 [TBL] [Abstract][Full Text] [Related]
10. Neurosteroids: A potential target for neuropsychiatric disorders. Wang M; Hu S; Fu X; Zhou H; Yang S; Yang C J Steroid Biochem Mol Biol; 2024 May; 239():106485. PubMed ID: 38369032 [TBL] [Abstract][Full Text] [Related]
13. The role of synthetic ligand of PPARα in regulation of transcription of genes related to mitochondria biogenesis and dynamic in an animal model of Alzheimer's disease. Żulińska S; Strosznajder AK; Strosznajder JB Folia Neuropathol; 2023; 61(2):138-143. PubMed ID: 37587888 [TBL] [Abstract][Full Text] [Related]
14. Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy. Strosznajder AK; Wójtowicz S; Jeżyna MJ; Sun GY; Strosznajder JB Neuromolecular Med; 2021 Mar; 23(1):86-98. PubMed ID: 33210212 [TBL] [Abstract][Full Text] [Related]
15. PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease. Kumar M; Ashok SA; Datusalia AK; Khatik GL Med Chem; 2024 May; ():. PubMed ID: 38726789 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands. Fidaleo M; Fanelli F; Ceru MP; Moreno S Curr Med Chem; 2014; 21(24):2803-21. PubMed ID: 24606520 [TBL] [Abstract][Full Text] [Related]